EXPERIMENTAL PROCEDURES

Protein preparation
The longest 441-residue splice-isoform of human Tau protein, 2N4R Tau, was recombinantly expressed and purified in 15 N and 13 C, 15 N-labeled form as described previously. 1,2 Purification of wild-type (MARK2cat) and the constitutively active T208E mutant of the catalytic domain of MARK2 (MARK2cat-T208E) was described elsewhere.
3,4
Peptide synthesis
Tau(254-284) peptides, roughly equivalent to the second half of R1 plus the first half of R2 and containing either a non-phosphorylated or phosphorylated Ser-262 residue,
were produced by standard Fmoc-solid-phase peptide synthesis using an ABI 433A synthesizer (Applied Biosystems). Peptides were synthesized with acetyl-and amide protection groups at the N-and C-termini, respectively. Peptides were further purified by reversed-phase HPLC and the pure product was lyophilized.
Sequential resonance assignment of 2N4R Tau
As described previously, 5 assignment was performed in an automated way using automated projection spectroscopy 6 
Ensemble Description
Ensemble descriptions of the phosphorylated and non-phosphorylated Tau(254-284) peptides were generated using a recently described protocol combining experimental NMR data, Monte-Carlo-based statistical coil sampling and ensemble selection. 20 The approach is briefly outlined below. 20000 conformers of phosphorylated and nonphosphorylated Tau(254-284) peptides that broadly sample the conformational space defined by amino acid-specific potential wells, using the statistical coil model
proposed by flexible-meccano. Chemical shifts were calculated for each member of the ensemble using the program SPARTA as previously described. 21, 22 from the phosphorylated amino acid were not included in the selection approach.
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